Some important biologics have experienced secondary patents to combinations with small molecule medication revoked in opposition proceedings before the EPO. A single cause why patents for biologic and compact molecule combos may well not constantly be robust is since the co-administration of two or maybe more medicines to take care https://rogerz221ulb0.blogdanica.com/profile